Description
Clinark-300 is a reliable injectable antibiotic formulated with Clindamycin, widely used in clinical settings to treat serious bacterial infections. Each 2 ml ampoule delivers an effective dose of Clindamycin Injection IP, making it suitable for hospitals and healthcare professionals managing moderate to severe infections.
Clindamycin belongs to the lincosamide class of antibiotics, known for its ability to inhibit bacterial protein synthesis. It is particularly effective against anaerobic bacteria, skin infections, bone and joint infections, respiratory tract infections, and intra-abdominal infections. Clinark-300 is often prescribed when patients are allergic to penicillin or when other antibiotics are less effective.
This injectable formulation ensures rapid absorption and faster therapeutic action, making it ideal for emergency or inpatient care. The compact 1×2 ml ampoule packaging ensures convenience, accurate dosing, and minimal wastage in clinical use.
Key benefits of Clinark-300:
- Broad-spectrum antibacterial coverage
- Effective against resistant bacterial strains
- Fast-acting injectable formulation
- Suitable for hospital and clinical use
With a competitive price of ₹127, Clinark-300 offers cost-effective infection management without compromising on quality. It is manufactured under stringent pharmaceutical standards to ensure safety, efficacy, and consistency.
Conclusion:
Clinark-300 (Clindamycin Injection IP 2 ml) stands out as a dependable antibiotic solution for healthcare providers seeking quick and effective bacterial infection control. Always administer under medical supervision to ensure optimal outcomes and patient safety.
